Creemers, Aafke http://orcid.org/0000-0002-7082-8183
Ebbing, Eva A.
Pelgrim, Thomas C.
Lagarde, Sjoerd M.
van Etten-Jamaludin, Faridi S.
van Berge Henegouwen, Mark I.
Hulshof, Maarten C. C. M.
Krishnadath, Kausilia K.
Meijer, Sybren L.
Bijlsma, Maarten F.
van Oijen, Martijn G. H.
van Laarhoven, Hanneke W. M.
Article History
Received: 17 April 2018
Accepted: 20 August 2018
First Online: 5 September 2018
Competing Interests
: Dr. Maarten F. Bijlsma has received research funding from Celgene. Dr. Martijn G. H. van Oijen has received unrestricted research grants from Bayer, Lilly, Merck Serono, and Roche. Prof. dr. Hanneke W. M. van Laarhoven has served as a consultant for Celgene, BMS, Lilly, and Nordic, and has received unrestricted research funding from Bayer, BMS, Celgene, Lilly, Merck Serono, MSD, Nordic, Philips and Roche. None of these parties was involved in drafting this review. All remaining authors have declared no conflicts of interest.